Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by wildbird1on Dec 07, 2024 9:08am
545 Views
Post# 36350852

Government grant/loans...maybe before year end....????

Government grant/loans...maybe before year end....????In all the previous updates, there was never a direct mention of a government program(grants/loans).

All of a sudden in a MP send to investors, TLT said...
'' Receiving approval for a Government program that could assist with our capitalization objective, this decision could come at any time between now and the end of the year''.

And now in the last earning update...
Theralase Technologies Inc. (TLTFF) Q3 2024 Earnings Call Transcript | Seeking Alpha

Kristina Hachey(TLT Chief Financial Officer) said...
'' The Company plans to raise approximately CAD$10 million in debt and/or equity instruments and government programs in the form of grant and loans to become shelf eligible(first time ever a direct mention of a Government grant/loans is made in an update)''.

Coincidence...????
These comments on Government programs grants/loans started to appear after this study by Dr. M. Coombs (University Of Manitoba, Medical and infectious disease) was published ...June 2024.
Nanomolar concentrations of the photodynamic compound TLD-1433 effectively inactivate numerous human pathogenic viruses: Heliyon

In this study Dr M.Coombs said...
Discussion...last paragraph...
'' The viral inactivation mediated  by TLD-1433-PDT induced ROS is effective against different families of viruses...and this opens potential opportunity to generate a broad spectrum of inactivated virus(es) vaccines with greater potency than vaccines produced by currenttly available inactivation techniques''.

Here is another interesting fact about Dr.M.Coombs...
profile - Kevin Coombs | Max Rady College of Medicine | University of Manitoba
In this link it is said...
''Dr M.Coombs has also served on various local, national, and international grant funding panel''.

All the above could be coincidences...But a Government grant/loans (even a very small one ) could be interpreted by investors as a good omen, and a proof that a team of Government scientists that evaluated the data provided by Dr M.Coombs came to the conclusion, that TLT compound(TLD-1433) has great virus and vaccine potential.
If a small grant/loans is approved and results are concluant, bigger grant/loans coud come later.

We could find out shortly(maybe before year end).
<< Previous
Bullboard Posts
Next >>